From oncoimmune perspectives, however, response predictive gene signatures revealed that a preexisting immunoreactive profile does not explicitly depend on suppressive tumor immune microenvironment represented by spatial CD8 and IFN-γ and colocalized PDL-1/IDO1 checkpoint genes. The gene discussed is CD8A; the disease is neoplasm.